Skip to main content
Log in

Over-the-counter oral nonsteroidal anti-inflammatory drugs: A pharmacoepidemiologic study in southern Italy

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

The Pharmacoepidemiologic Service of the Second University of Naples analyzed the use and tolerability of over-the-counter (OTC) oral nonsteroidal antiinflammatory drugs (NSAIDs) purchased in Campania, a region of southern Italy. Forty private pharmacies uniformly distributed throughout the region were recruited. The study was conducted by means of a questionnaire completed by purchasers and lasted from December 1, 1999 to March 31, 2000; 2053 questionnaires were collected. The age of respondents averaged 45.3 ± 3.49 years (range, 17–85 years). The NSAIDs analyzed were acetylsalicylic acid, paracetamol, ibuprofen, ketoprofen, diclofenac, and piroxicam. Adverse effects, mainly gastrointestinal symptoms, were reported by 5.5% of the users and occurred primarily with diclofenac, piroxicam, ibuprofen, and ketoprofen. Because the use and availability of OTC NSAIDs are increasing, further studies of the tolerability of this important drug class are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Blenkinsopp A, Bradley C. Patients, society and the increase in self-medication.BMJ. 1996; 312:629–632.

    PubMed  CAS  Google Scholar 

  2. Bradley C, Bond CM. Increasing the number of drugs available over-the-counter: arguments for and against.Br J Gen Pract. 1995;45:553–556.

    PubMed  CAS  Google Scholar 

  3. Gossel TA. Implications of the reclassification of drugs from prescription-only to over-the-counter status.Clin Ther. 1991;13:200–215.

    PubMed  CAS  Google Scholar 

  4. Ryan M, Yule B. Switching drugs for prescription-only to over-the-counter availability: economic benefit in the United Kingdom.Health Policy. 1990;16:233–239.

    Article  PubMed  CAS  Google Scholar 

  5. Smith MC. Prescription to OTC switches: reflections and projections.Drug Top. 1998;142:70–79.

    Google Scholar 

  6. Barber N. Drugs: from prescription only to pharmacy only.BMJ. 1993;307:640.

    PubMed  CAS  Google Scholar 

  7. Schmid B. The safety assessment of over-the-counter products.Arch Toxicol. 1995;17:305–311.

    CAS  Google Scholar 

  8. Volans G. Monitoring the safety of over the counter drugs.BMJ. 1987;295:797–798.

    PubMed  CAS  Google Scholar 

  9. Montastruc JL, Bagheri H, Geraud T. Pharmacovigilance of self-medication.Therapie. 1997; 52:105–110.

    PubMed  CAS  Google Scholar 

  10. Levy M. Adverse reactions to over-the-counter analgesics: an epidemiologic evaluation.Agents Actions. 1988;25:21–31.

    CAS  Google Scholar 

  11. Garnett WR. GI effects of OTC analgesic: implications for product selection.J Am Pharm Assoc. 1996;NS36:565–572.

    CAS  Google Scholar 

  12. Blot WJ, McLaughlin JK. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding.J Epidemiol Biostat. 2000;5:137–142.

    PubMed  CAS  Google Scholar 

  13. Ceci A. OTC: situazione europea e realtá italiana. In:Atti del primo Forum Internazionale di Self-Medication. Intermedia: Brescia; 1996:51–58.

    Google Scholar 

  14. Sihvo S, Klaukka T, Martikainen J, Hemminki E. Frequency of daily over-the-counter drug use and potentially significant overprescription drug interactions in the Finnish adult population.Eur J Clin Pharmacol. 2000;56:495–499.

    Article  PubMed  CAS  Google Scholar 

  15. Nykamp D, Bernett CW, Hooper C. Risk of adverse drugs events related to ibuprofen use in a community sample.J Pharmacol Technol. 1994;10:110–114.

    Google Scholar 

  16. Honig PK, Gillespie BK. Drug interactions between prescribed and over-the-counter medication.Drug Saf. 1995;13:296–303.

    PubMed  CAS  Google Scholar 

  17. Gaulg NJ, Shaw JP, Emmerton LM, Pethica BD. Surveillance of a recently switched non-prescription medicine (diclofenac) using a pharmacy-based approach.Pharmacoepidemiol Drug Saf. 2000; 9:207–214.

    Article  Google Scholar 

  18. Bond CM, Bradley C. Over-the-counter drugs: the interface between the community pharmacist and patients.BMJ. 1996;312:758–760.

    PubMed  CAS  Google Scholar 

  19. Gibson P, Henry D, Francis L. Association between availability of non-prescription beta-2-agonist inhalers and undertreatment of asthma.BMJ. 1993;306:1514–1518.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Motola, G., Russo, F., Mazzeo, F. et al. Over-the-counter oral nonsteroidal anti-inflammatory drugs: A pharmacoepidemiologic study in southern Italy. Adv Therapy 18, 216–222 (2001). https://doi.org/10.1007/BF02853167

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02853167

Keywords

Navigation